Australia's most trusted
source of pharma news
Monday, 15 June 2026
Posted 15 June 2026 PM
The GBMA will throw its two cents in to a High Court hearing that will determine the fate of many products listed on the PBS.
Tomorrow the High Court of Australia will hear arguments in a case that has reverberated across the pharmaceutical industry by threatening to cut short the exclusivity period of a high number of drugs. The GBMA has been granted leave to intervene as a 'friend of the court'.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.